Gek Keow Lim is a prominent inventor based in Singapore, known for his significant contributions to the field of hepatitis B research. With a total of 6 patents to his name, Lim has made strides in understanding and combating this viral infection.

Latest Patents

One of Lim's latest patents is focused on a mutant human hepatitis B viral strain and its uses. This invention provides an isolated strain of Hepatitis B virus designated Human Hepatitis B Virus Surface Antigen-'S'-133 Oon Strain, which has a unique amino acid sequence. The patent also includes an isolated nucleic acid encoding a polypeptide that differs from the wild type hepatitis B virus. Another notable patent involves an in vitro activity assay for human hepatitis B virus DNA polymerase. This assay is designed to screen for inhibitors of HBV DNA polymerase and test potential anti-HBV drugs.

Career Highlights

Throughout his career, Gek Keow Lim has worked with the Government of the Republic of Singapore, contributing his expertise to various research initiatives. His work has been instrumental in advancing the understanding of hepatitis B and developing potential treatments.

Collaborations

Lim has collaborated with notable colleagues such as Chong Jin Oon and Wei Chen, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Gek Keow Lim's innovative work in hepatitis B research has led to significant advancements in the field. His patents reflect a commitment to improving health outcomes and understanding viral infections.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com